Zahraei, M., Azimi, Y., Karimipour, M., Rahimi-Jamnani, F., Valizadeh, V., Azizi, M. (2025). CRISPR/dCas9-TET1–mediated epigenetic editing reactivates miR-200c in breast cancer cells. Scientific Reports. https://doi.org/10.1038/s41598-025-16911-8